GSK sells two vaccines to Pfizer to ease competition concerns
0
LONDON (Reuters) - GlaxoSmithKline has agreed to sell two meningitis vaccines to Pfizer to satisfy antitrust concerns after its recent acquisition of vaccines business of Novartis.